A Phase 1 Trial of Vorinostat and Pegylated Liposomal Doxorubicin In Relapsed or Refractory Lymphoma

被引：0
|
作者：
Lansigan, Frederick [1 ]
Seropian, Stuart [2 ]
Cooper, Dennis L. [2 ]
Potter, Von [2 ]
Sowers, Noelle [2 ]
Foss, Francine M. [3 ]
机构：
[1] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
[2] Yale Univ, Sch Med, Dept Med Oncol, New Haven, CT USA
[3] Yale Med Oncol, New Haven, CT USA
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1161 / 1162
页数：2
相关论文
共 50 条
  • [1] Final Results of a Phase 1 Study of Vorinostat, Pegylated Liposomal Doxorubicin, and Bortezomib in Relapsed or Refractory Multiple Myeloma
    Voorhees, Peter M.
    Gasparetto, Cristina
    Moore, Dominic T.
    Winans, Diane
    Orlowski, Robert Z.
    Hurd, David D.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (07): : 424 - 432
  • [2] Vorinostat in Combination with Pegylated Liposomal Doxorubicin and Bortezomib for Patients with Relapsed/Refractory Multiple Myeloma: Results of a Phase I Study
    Voorhees, Peter M.
    Gasparetto, Cristina
    Richards, Kristy L.
    Garcia, Reynaldo
    Strader, John S.
    Ferraro, Madlyn
    MacLean, Jennifer
    Winans, Diane
    Moore, Dominic T.
    Dodd, Andrew
    Foster, Matthew C.
    Gabriel, Don A.
    Shea, Thomas C.
    Serody, Jonathan
    van Deventer, Hendrik W.
    Rizvi, Syed
    Orlowski, Robert Z.
    Hurd, David D.
    [J]. BLOOD, 2009, 114 (22) : 129 - 130
  • [3] A phase II trial of decitabine, bortezomib and pegylated liposomal doxorubicin for the treatment of relapsed or refractory AML
    Jonas, Brian A.
    Potter, Laura A.
    Galkin, Maria
    Tuscano, Joseph M.
    [J]. LEUKEMIA RESEARCH REPORTS, 2023, 19
  • [4] Results of a Phase I Study of Vorinostat In Combination with Pegylated Liposomal Doxorubicin and Bortezomib In Patients with Relapsed/Refractory Multiple Myeloma
    Voorhees, Peter M.
    Gasparetto, Cristina
    Osman, Keren
    Richards, Kristy
    Ferraro, Madlyn
    Garcia, Reynaldo
    MacLean, Jennifer
    Winans, Diane
    Moore, Dominic
    Strader, John
    Orlowski, Robert Z.
    Hurd, David Duane
    [J]. BLOOD, 2010, 116 (21) : 815 - 816
  • [5] A Phase 1/2 Trial of Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Patients with Relapsed/Refractory Multiple Myeloma
    Berenson, James R.
    Stampleman, Laura V.
    Bessudo, Alberto
    Rosen, Peter J.
    Klein, Leonard M.
    Woliver, Thomas
    Flam, Marshall S.
    Eshaghian, Shahrooz
    Nassir, Youram
    Swift, Regina A.
    Vescio, Robert
    [J]. BLOOD, 2014, 124 (21)
  • [6] a Phase 1/2 Trial of Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
    Berenson, James
    Stampleman, Laura
    Bessudo, Alberto
    Rosen, Peter J.
    Klein, Leonard M.
    Woliver, Thomas
    Flam, Marshall S.
    Eshaghian, Shahrooz
    Nassir, Youram
    Regina, Swift A.
    James, Wang
    Benjamin, Eades
    Spektor, Tanya M.
    Vescio, Robert
    [J]. BLOOD, 2015, 126 (23)
  • [7] Pegylated liposomal doxorubicin and bortezomib in relapsed/refractory multiple myeloma
    不详
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2007, 7 (07): : 453 - 455
  • [8] A Phase I/II Trial of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma
    Schroeder, Mark A.
    Fiala, Mark A.
    Huselton, Eric
    Cardone, Michael H.
    Jaeger, Savina
    Jean, Sae Rin
    Shea, Kathryn
    Ghobadi, Armin
    Wildes, Tanya
    Stocked-Goldstein, Keith E.
    Vij, Ravi
    [J]. CLINICAL CANCER RESEARCH, 2019, 25 (13) : 3776 - 3783
  • [9] A Phase I Study of Carfilzomib and Pegylated Liposomal Doxorubicin for Relapsed or Refractory Multiple Myeloma
    Keller, Jesse
    Fiala, Mark A.
    Sekhar, Jeevan
    Ceriotti, Connie
    Allen, Melissa
    Abboud, Camille N.
    Stockerl-Goldstein, Keith E.
    Wildes, Tanya M.
    Tomasson, Michael H.
    Vij, Ravi
    [J]. BLOOD, 2014, 124 (21)
  • [10] A Phase 1/2 Study of Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Patients with Relapsed/Refractory Multiple Myeloma
    Berenson, James R.
    Hilger, James D.
    Klein, Leonard M.
    Eshaghian, Shahrooz
    Nassir, Youram
    Swift, Regina A.
    Vescio, Robert
    [J]. BLOOD, 2012, 120 (21)
12345